<DOC>
	<DOCNO>NCT02886156</DOCNO>
	<brief_summary>Multiple clinical study indicate obstructive sleep apnea ( OSA ) , common chronic sleep disorder , may affect neurocognitive function , treatment continuous positive airway pressure ( CPAP ) neurocognitive protective effect adverse effect OSA . However , effect CPAP treatment neurocognitive architecture function remain unclear . Therefore , multicenter trial design investigate whether neurocognitive architecture function patient OSA improve CPAP treatment , explore role gut microbiota improve neurocognitive function treatment.This study multicenter , randomize , control trial allocation concealment assessor blinding . A total 148 eligible patient severe OSA enrol five sleep center , randomize receive CPAP best supportive care ( BSC ) intervention BSC intervention alone . Cognitive function , structure function brain region , gut microbiota , metabolite , biochemical variable , electrocardiography , echocardiography , pulmonary function , arterial stiffness assess baseline randomization 3 , 6 , 12 month . In addition , investigator enroll 74 healthy control assess aforementioned variable baseline .</brief_summary>
	<brief_title>Effects CPAP Cognitive Function , Neurocognitive Architecture Function Patients With OSA : The SMOSAT Trial</brief_title>
	<detailed_description>Background Multiple clinical study indicate obstructive sleep apnea ( OSA ) , common chronic sleep disorder , may affect neurocognitive function , treatment continuous positive airway pressure ( CPAP ) neurocognitive protective effect adverse effect OSA . However , effect CPAP treatment neurocognitive architecture function remain unclear . Therefore , multicenter trial design investigate whether neurocognitive architecture function patient OSA improve CPAP treatment , explore role gut microbiota improve neurocognitive function treatment . Methods/Design This study multicenter , randomize , control trial allocation concealment assessor blinding . A total 148 eligible patient severe OSA enrol five sleep center , randomize receive CPAP best supportive care ( BSC ) intervention BSC intervention alone . Cognitive function , structure function brain region , gut microbiota , metabolite , biochemical variable , electrocardiography , echocardiography , pulmonary function , arterial stiffness assess baseline randomization 3 , 6 , 12 month . In addition , investigator enroll 74 healthy control assess aforementioned variable baseline . Ethics Dissemination Ethics approval give Medical Ethics Committee Shanghai Jiao Tong University Affiliated Sixth People 's Hospital ( approval number 2015-79 ) . The finding study disseminate peer-reviewed journal conference .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>1 . Informed consent 2 . Age 3065 year 3 . Newly diagnose OSA ( fullnight inlaboratory polysomnography [ PSG ] AHI â‰¥ 30 event per hour ) 4 . Adherence CPAP treatment 5 . No participation clinical trial past 3 month 6 . Able accomplish relevant test followup 1 . Severe systemic disease ( e.g. , cardiac , hepatic , renal failure ) 2 . Psychiatric condition ( e.g. , depression , mania , schizophrenia ) 3 . Neurological disease ( e.g. , head trauma , brain tumor , epilepsy , stroke , transient ischemic attack , coma ) 4 . Sleep disorder OSA ( narcolepsy , insomnia , chronic sleep deprivation , rapid eye movement [ REM ] behavior disorder restless legs syndrome , central sleep apnea obesity hypoventilation syndrome ) 5 . Alcoholism , drug addiction , use psychotropic drug , sedative , narcotic 6 . Prior therapy OSA ( i.e. , CPAP , upper airway surgery , oral appliance ) 7 . Minimum Mental State Examination ( MMSE ) &lt; 24 8 . Lefthanded 9 . MRI contraindication ( e.g. , claustrophobic metal implantation ) 10 . Gastrointestinal surgery last year , except appendicitis hernia surgery 11 . Pregnancy 12 . Use intestinal flora regulator ( e.g. , antibiotic probiotic ) previous 8 week 13 . Medical treatment cholecystitis , gallstone , gastrointestinal ulcer , urinary tract infection , acute pyelonephritis , cystitis past 3 month 14 . Infectious disease , tuberculosis , acquire immune deficiency syndrome 15 . Deemed researcher suitable trial</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>OSA</keyword>
	<keyword>CPAP</keyword>
	<keyword>cognitive function</keyword>
	<keyword>gut microbiota</keyword>
	<keyword>metabolomics</keyword>
</DOC>